Research ArticleClinical Investigations
Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response
Matt Vanderhoek, Scott B. Perlman and Robert Jeraj
Journal of Nuclear Medicine January 2012, 53 (1) 4-11; DOI: https://doi.org/10.2967/jnumed.111.093443
Matt Vanderhoek
Scott B. Perlman

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 53, Issue 1
January 1, 2012
Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response
Matt Vanderhoek, Scott B. Perlman, Robert Jeraj
Journal of Nuclear Medicine Jan 2012, 53 (1) 4-11; DOI: 10.2967/jnumed.111.093443
Jump to section
Related Articles
Cited By...
- A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
- Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET
- Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer
- Additional value of volumetric and texture analysis on FDG PET assessment in paediatric Hodgkin lymphoma: an Italian multicentric study protocol
- Digital Solid-State SPECT/CT Quantitation of Absolute 177Lu Radiotracer Concentration: In Vivo and In Vitro Validation
- Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study
- Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with 18F-FDOPA and 18F-FDG PET
- Quantitation of Cancer Treatment Response by 18F-FDG PET/CT: Multicenter Assessment of Measurement Variability
- Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients
- SUVpeak Performance in Lung Cancer: Comparison to Average SUV from the 40 Hottest Voxels
- Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
- Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study
- Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease
- Assessment of Simplified Methods to Measure 18F-FLT Uptake Changes in EGFR-Mutated Non-Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor Treatment
- Prediction of Survival by [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non-Small-Cell Lung Cancer Undergoing Definitive Chemoradiation Therapy: Results of the ACRIN 6668/RTOG 0235 Trial
- Impact of Different Standardized Uptake Value Measures on PET-Based Quantification of Treatment Response
- Differences in the Biologic Activity of 2 Novel MEK Inhibitors Revealed by 18F-FDG PET: Analysis of Imaging Data from 2 Phase I Trials
- Mutatis Mutandis: Harmonize the Standard!